Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/ph14030217

http://scihub22266oqcxt.onion/10.3390/ph14030217
suck pdf from google scholar
33807743!8001969!33807743
unlimited free pdf from europmc33807743    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid33807743      Pharmaceuticals+(Basel) 2021 ; 14 (3): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Rapamycin: Drug Repurposing in SARS-CoV-2 Infection #MMPMID33807743
  • Patocka J; Kuca K; Oleksak P; Nepovimova E; Valis M; Novotny M; Klimova B
  • Pharmaceuticals (Basel) 2021[Mar]; 14 (3): ä PMID33807743show ga
  • Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with enormous consequences for human health and the world economy. Remdesivir is the only drug in the world that has been approved for the treating of COVID-19. This drug, as well as vaccination, still has uncertain effectiveness. Drug repurposing could be a promising strategy how to find an appropriate molecule: rapamycin could be one of them. The authors performed a systematic literature review of available studies on the research describing rapamycin in association with COVID-19 infection. Only peer-reviewed English-written articles from the world's acknowledged databases Web of Science, PubMed, Springer and Scopus were involved. Five articles were eventually included in the final analysis. The findings indicate that rapamycin seems to be a suitable candidate for drug repurposing. In addition, it may represent a better candidate for COVID-19 therapy than commonly tested antivirals. It is also likely that its efficiency will not be reduced by the high rate of viral RNA mutation.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box